Numerous clinical trials are always active (ie, open and enrolling patients) in the ECOG-ACRIN Cancer Research Group, which focuses its research on adults who have or are at risk of developing cancer. The buttons below depict the general research categories being investigated in ECOG-ACRIN clinical trials. To access information within a particular category, click on the relevant button. Upon clicking, the color of the button will change from grey to red, and a table will appear on screen. The table will display the study number, study description, lead investigator(s), accrual goal, and the date participating institutions started to open the trial. Please read the ECOG-ACRIN Disclaimer in its entirety before accessing this information.
To view educational materials, click on the links provided in the Educational Materials column. To send an email to the study chair, click on their name and a new email window will open.
Head and Neck Cancer Trials Currently Recruiting Participants (Thyroid, Larynx (Voice Box), Throat, Lips, Mouth, Nose, and Salivary Glands)
STUDY DESCRIPTION ECOG-ACRIN STUDY CHAIR
EA3132 Phase II Randomized Trial of Adjuvant Radiotherapy with or without Cisplatin for p53 Mutated, Surgically Resected Squamous Cell Carcinoma of the Head and Neck Robert L. Ferris, MD, PhD, Chair
Christine H. Chung, MD, Co-Chair
(Shuli Li, PhD)
345 03/29/2016 EA3132 Resources
EA3163 Phase II Randomized Trial of Neoadjuvant Chemotherapy Followed by Surgery and Post-operative Radiation versus Surgery and Post-operative Radiation for Organ Preservation of T3 and T4a Nasal and Paranasal Sinus Squamous Cell Carcinoma (NPNSCC) Nabil F. Saba, MD, FACP, Chair
(Shuli Li, PhD)